Related Experiment Video
Updated: Aug 27, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
A 40-Year-Old Woman With COVID-19 and Bilateral Vision Loss
Varun Jain1, Alexander J Senetar1, Carolina B Maciel2
1Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA.
Abstract:
Mucormycosis is a fast-spreading angioinvasive fungal infection with a very high mortality rate. It is associated with immunodeficiency, diabetes mellitus, iron overload, stem cell transplantation and the use of steroids. As cultures and histopathological biopsy may have low yield in invasive fungal infections, new generation sequencing of cfDNA (cell free deoxyribonucleic acid) has become a cornerstone for diagnosis. Over the past 18 months, increasing reports of COVID-19 associated Mucormycosis have emerged, most specifically in India and other nearby developing countries. Awareness and knowledge of this newly discovered association is of high importance and clinical relevance as the global COVID-19 pandemic continues. Herein, we present a case of a patient who was treated with steroids for COVID-19 in the outpatient setting and presented with unilateral periorbital pain and blurry vision. She progressively developed bilateral vision loss, fixed bilateral mydriasis, ophthalmoplegia and coma. Imaging findings included leptomeningeal, vascular, and subcortical enhancement accompanied with multifocal infarction. Subsequent biopsy of the paranasal sinuses revealed broad type fungal elements and cfDNA sequencing identified the pathogen as Rhizopus species. She was treated with intravenous amphotericin B, but succumbed to the infection.
Insights
Mucormycosis, a dangerous fungal infection, is increasingly linked to COVID-19 treatments like steroids. Early diagnosis using cell-free DNA sequencing is crucial but challenging, as highlighted by a fatal case report.
Area of Science:
- Mycology
- Infectious Diseases
- Neurology
Background:
- Mucormycosis is a severe angioinvasive fungal infection with high mortality.
- Risk factors include immunodeficiency, diabetes, iron overload, stem cell transplant, and steroid use.
- COVID-19 associated mucormycosis (CAM) has emerged as a significant clinical concern, particularly in developing nations.
Purpose of the Study:
- To highlight the clinical presentation and diagnostic challenges of COVID-19 associated mucormycosis.
- To emphasize the utility of next-generation sequencing of cell-free DNA (cfDNA) in diagnosing invasive fungal infections.
- To present a case illustrating the rapid progression and poor prognosis of CAM.
Main Methods:
- Case report of a patient treated with steroids for COVID-19.
- Clinical examination, neuroimaging (leptomeningeal, vascular, and subcortical enhancement, multifocal infarction).
- Paranasal sinus biopsy and next-generation sequencing of cfDNA for pathogen identification.
Main Results:
- The patient developed severe neurological complications including bilateral vision loss, ophthalmoplegia, and coma.
- Imaging revealed characteristic patterns of central nervous system involvement.
- Biopsy confirmed fungal elements, and cfDNA sequencing identified Rhizopus species.
Conclusions:
- COVID-19 associated mucormycosis is a critical, rapidly progressing infection.
- Cell-free DNA sequencing offers a valuable diagnostic tool for invasive fungal infections.
- Despite treatment with amphotericin B, the patient succumbed to the infection, underscoring the severity of CAM.
More Related Videos
07:12Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
Published on: April 11, 2025
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Related Concept Videos
Photoreceptors and Visual Pathways
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Prosopagnosia
Visual Agnosia